Hello everyone,

For any hospitals with over 300 beds, what is your med safety reporting/meeting structure?

Do you have a separate Med Safety committee? If yes, what is its oversight committee? Does it go to P&T, another overall hospital quality group, or something else?

Or is your Med Safety report out/discussion part of a different group (i.e., not a stand alone committee). In this case, how do you organize report outs vs granular safety event discussions?

Any information/details would be greatly appreciated.

Thank you!

-Saduf

Hi Everyone,

I'm reaching out with a question raised by our IV team regarding the placement of labels on compounded IVPB products.

Specifically, where do you place the IV label—on the front or the back of the bag? If placed on the front, does the label cover the name of the diluent? Currently, our practice is inconsistent—some technicians place the label on the front of the IVPB, while others apply it to the back. When placed on the front, the label sometimes covers the name of the diluent, which has led to questions about whether this is preferred or should be avoided.

We have identified opportunities with Ultomiris/Soliris REMS requirements, noteably with:
• Meningococcal vaccine series prior to administration, booster after 1 year, and every 2-3 years after
• Antimicrobial prophylaxis required if above not met

We are interested to see what other sites are doing to ensure compliance.
Thanks!
Maria Cumpston, PharmD, CPPS
Medication Safety Officer & Compliance Director
WVU Hospitals
304-598-4000 ext 73356

Hi,
Wanted to get some insight on how other hospitals handle ordering pre- procedure medications? Are they ordered as 'once' orders? or 'once PRN'? We have had some errors in both instances. With the 'once' orders, sometimes these medications get given too early (ie. surgical prophylaxis antimicrobials) but with the 'once PRN' medications, we have had instances where the medication is not given.
Thanks!

Any cardiac centers willing to share their setup/default settings for ordering a titratable dobutamine and/or milrinone here or via fiona.lui@swedish.org

Providers at my institution have proposed that:

-Dobutamine dosing range should be limited 0-10 mcg/kg/min despite Lexicomp's dosing range of 0-20 mcg/kg/min.

-Milrinone dosing range should not exceed 0.375 mcg/kg/min despite Lexicomp's range: 0.125 - 0.75 mcg/kg/minute.

Do you store concentrated electrolytes in your pharmacy carousel? If yes, what safeguards do you have implemented?

Hello,
Can sodium phosphate vials - concentrated electrolyte be stocked in medication rooms in dispensing cabinets. Is there an ISMP reference.

My facilities are ambulatory surgical centers and do not have automated dispensing machines. The OR suites have drawers with open (cup-like) labeled bins containing the various OR medications. Sugammadex is contained in these drawers and would be exposed to light upon opening the drawer. There is potential for extended light exposure if the drawer is left open during a case. The package insert for the medication states that if the medication is exposed to light, it should have a 5 day expiration. How are other facilities handling this?

Hello!

Has anyone partnered with VaxCare for their immunization practices? (https://www.vaxcare.com/?nab=1)

Looking for a larger organization using this program to connect with.... also, curious if you had already incorporated ambulatory BCMA scanning into your practices.

Thanks in advance!
Emily

Our organization is currently using 50 mL of overfill for our pediatric TPNs. We have been finishing about 40 minutes to 1 hour early but this is within the expected flow rate for our pumps. Wondering if we need to increase our overfill.